RxDoctor Payments Data

Michelle Garrett

Psychiatric/Mental Health · Creve Coeur, MONPI 1235894262

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 356 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,607, more than ten times the $78 reported in 2021. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,839in general payments, 2019–2025

Across 356 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Teva Pharmaceuticals USA, Inc.$913
  • AbbVie$578
  • Vanda Pharmaceuticals Inc.$553
  • Lundbeck LLC$517
  • Otsuka America Pharmaceutical, Inc.$251
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$5,78099%
  • Education$591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,839 in reported general payments places this provider in the 90th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$10,532
Medicare patients
15
Services billed
121

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Desvenlafaxine Succinate ErDesvenlafaxine Succinate19$1,347
Divalproex Sodium ErDivalproex Sodium12$793
Bupropion XlBupropion Hcl45$573
Clomipramine Hcl12$360
Lamotrigine16$287
Buspirone Hcl15$273
Trazodone Hcl29$127
Duloxetine Hcl13$121

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Creve Coeur

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →